Gene Therapy Market is expected to reach the Value of USD 12.46 Billion, with Growing CAGR of 20.9% by the end of 2029, Size, Share, Growth, Demand and Opportunity Outlook
Several companies are involved in strategic alliances to boost their offerings in the space, that is projected to strengthen the market competition during the forecast period
NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) -- A recent study report released by *Data Bridge Market research* titled “*Gene Therapy Market*” guarantees you will remain better informed than your competition. The Gene Therapy research offers a comprehensive background analysis of the Gene Therapy industry, which also includes an examination of the market for parents. The study of competitors is one of the most significant components of a report on market research since it enables businesses to choose their strategies by evaluating how those strategies compare to those of their rivals. This Gene Therapy market research report was meticulously crafted by a group of researchers, analysts, and industry professionals that worked together while keeping the perspective of the customer in mind during the entire process. In order to ensure the success of your company on an international level, we have compiled a global market study of the highest possible quality. In addition, clients are made aware, via the usage of this Gene Therapy market research study, of the numerous techniques that are utilized by major competitors in the market.
Data Bridge Market Research analyses a growth rate in the global gene therapy market in the forecast period 2022-2029. The expected CAGR of the global gene therapy market tends to be *around 20.9%* in the mentioned forecast period. The market was valued at USD 2.73 billion in 2021, and it *would grow up to USD 12.46 billion by 2029*. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
*Get an Exclusive Sample of the **Gene Therapy **Market Report in PDF Version @** https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-gene-therapy-market*
*Gene therapy* is a method of inserting genes into tissues and cells to treat any type of disease. In this method, the defective gene is replaced with a functional gene. It is the strategy of manipulating of expression of certain genes as the cause for the disease. This treatment is very helpful in treating a number of diseases.
Therapy developers are investing in collaboration or mergers and acquisitions as a feasible strategy to enhance in-house expertise and strengthen product pipelines. Spinal Muscular Atrophy (SMA) acquired the highest share in 2020 with a maximum revenue share of over 41%. The large B-cell lymphoma segment is projected to account for the maximum revenue share by 2028.
*The Global Research Report Provides a Detailed Analysis of Market. Based on Competitive Intensity and How the Competition Will Take Shape in Coming Years.*
The Global Gene Therapy Market is witnessing a tremendous growth owing to the rapidly rising demands, a surge in industrialization, consumer awareness, emerging industries, and technological advancements. The industry has reported exponential revenue growth and sales volume. Factors driving the growth of the market are anticipated to boost the market size and boost the growth of the market throughout the forecast period.
The leading companies of the *Gene Therapy industry* are engaging in various developmental activities such as product developments, extensive product research, innovations, and advancements in product processes to re-launch updated products in the market to gain substantial customer base and market size. The report consists of all the business strategies adopted by the companies along with their financial standing, revenue, gross margin, and growth rate.
*Some of the major players operating in the Gene Therapy market are*
· AbbVie Inc. (U.S.)
· Bausch Health Companies Inc. (Canada)
· Teva Pharmaceutical Industries Ltd. (Israel)
· Cipla Inc. (India)
· Lupin (India)
· Sun Pharmaceuticals Industries Ltd. (India)
· Hikma Pharmaceuticals PLC (U.K.)
· AstraZeneca (U.K.)
· GSK Plc. (U.K.)
· Pfizer Inc. (U.S.)
· Amneal Pharmaceuticals LLC. (U.K.)
· Alvogen (U.S)
· F. Hoffmann-La Roche Ltd (Switzerland)
· Amgen Inc. (U.S.)
· Jazz Pharmaceuticals, Inc. (U.K.)
· Amicus Therapeutics, Inc (U.S.)
· MeiraGTx Limited (U.S.)
· Rocket Pharmaceuticals, Inc. (U.S.)
· Gilead Sciences, Inc. (U.S.)
*Access Full PDF Research Report @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-gene-therapy-market*
*Opportunities*
· *Increased Drug Approvals*
The growing drug approvals for treating this rare condition create many market opportunities. For instance, Novartis and Gilead continue to expand their customer base worldwide for Kymriah and Yescarta, designed to treat large B-cell lymphoma. It has been seen that in May 2019, Novartis received approval to sell its products in Japan. Furthermore, in 2017, about 51% of patients who received Yescarta treatment achieved remission.
· *Higher Strategic Alliances*
Several companies are involved in strategic alliances to boost their offerings in the space, that is projected to strengthen the market competition during the forecast period. For instance, in March 2020, REGENXBIO, Inc. and Ultragenyx Pharmaceutical, Inc. collaborated for the NAV technology platform. Under this deal, Ultragenyx Pharmaceutical, Inc. received a global license to REGENXBIO’s NAV AAV9 and AAV8 vectors for the development of multiple gene therapies for a rare metabolic disorder
*Critical Insights Related to the **Gene Therapy Included in the Report:*
· Exclusive graphics and Illustrative SWOT analysis of some of the leading companies in this market
· Value chain analysis of prominent players in the market
· Current trends influencing the dynamics of this market across various geographies
· Recent mergers, acquisitions, collaborations, and partnerships
· Revenue growth of this industry over the forecast period
· Marketing strategy study and growth trends
· Growth-driven factor analysis
· Emerging recess segments and region-wise market
· An empirical evaluation of the curve of the *Gene Therapy Industry*
· Ancient, Present, and Probable scope of the market from both prospect value and volume
*Segmentation Covered: Gene Therapy Market*
*By Gene Type*
· Antigen
· Cytokine
· Suicide
*By Viral Vector*
· Retroviruses
· Herpes Simplex Virus
· Adenoviruses
*By Non-Viral Vector*
· Naked or Plasmid Vectors
· Electroporation
*By Application*
· *Oncology*
· Rare Diseases
· Infectious Disease
*By End User*
· Hospitals
· Homecare
· Specialty Clinics
*By Distribution Channel*
· Hospital Pharmacy
· Online Pharmacy
· Retail Pharmacy
*Browse a Detailed Summary of the Research Report @** https://www.databridgemarketresearch.com/reports/global-gene-therapy-market*
*Gene Therapy Market Regional Analysis/Insights:*
The major countries covered in the *gene therapy market report* are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
*North America has been witnessing positive growth* in the gene therapy market throughout the forecast period due to the sturdy regulatory framework for promoting cellular therapy development.
*Asia-Pacific dominates* the market due to the rise in the acceptance of unique treatment options.
*Benefits of Considering this report:*
· This report is compiled using a vigorous and thorough research methodology. Data Bridge Market Research is also known for its data accuracy and granular market reports.
· A complete picture of the competitive scenario of Gene Therapy market is depicted by this report.
· The *gene therapy report* consists of a vast amount of data about the recent product and technological developments in the markets.
· The extensive spectrum of analysis regarding the impact of these advancements on the future of market growth.
· The insights in the report are easy to understand and include a graphical representation of the numbers in the form of histograms, bar graphs, pie charts, etc.
· Components such as market drivers, restraints, challenges, and opportunities for Gene Therapy market are explained in detail.
· It also provides a complete assessment of the expected behavior about the future market and changing market scenario.
· Making an informed business decision is a tough job; this report offers several strategic business methodologies to support you in making those decisions.
*Table of Contents:*
1. Introduction
2. Market Segmentation
3. Executive Summary
4. Premium Insights
5. Global Gene Therapy Market: Regulations
6. Market Overview
7. *Global Gene Therapy Market*, By Gene Type
8. Global Gene Therapy Market, By Viral Vector
9. Global Gene Therapy Market, By Non-Viral Vector
10. Global Gene Therapy Market, By Application
11. Global Gene Therapy Market, By End User
12. Global Gene Therapy Market, By Distribution Channel
13. Global Gene Therapy Market, By Region
14. Global Gene Therapy Market: Company Landscape
15. SWOT Analyses
16. Company Profile
17. Questionnaires
18. Related Reports
*For More Insights Grab Full TOC @** https://www.databridgemarketresearch.com/toc/?dbmr=global-gene-therapy-market*
*Browse More Reports: *
· *Gene Therapy Products Market*, By Product (Yescarta, Kymriah, Luxturna, Strimvelis and Gendicine), Application (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases and Other Diseases), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-gene-therapy-products-market
· *Cancer Gene Therapy Market*, By Therapy (Oncolytic Virotherapy, Gene Induced Immunotherapy, Gene Transfer), End User (Hospitals, Oncology Institutes, Biotechnological Companies, Clinical Research Laboratories) https://www.databridgemarketresearch.com/reports/global-cancer-gene-therapy-market
· *Stem Cell and Gene Therapy Biological Testing Market*, By Product Type (Cell Therapy and Gene Therapy), End Users (Hospitals, Wound Care Centres, Cancer Care Centres, Ambulatory Surgical Centres and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-stem-cell-and-gene-therapy-biological-testing-market
· *Cell and Gene Therapy Thawing Equipment Market*, By Modality (Benchtop and Portable), Sample (Cell Therapies and Gene Therapies), Type (Manual Thawing System and Automatic Thawing System), Application (Upstream Processing and Downstream Processing), End User (Blood Banks And Transfusion Centers, Hospitals and Diagnostic Laboratories, Research Laboratories And Academic Institutes, Biotechnology and Pharmaceutical Industry, Cord Blood and Stem Cell Banks, Gene Banks and Others), Distribution Channel (Direct Tender, Third Part Distributor and Others), Country (U.S., Canada, Mexico, U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Ireland, Rest of Europe, China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E., Egypt, Israel and Rest of Middle East and Africa, Brazil, Argentina and Rest of South America) https://www.databridgemarketresearch.com/reports/global-cell-and-gene-therapy-thawing-equipment-market
· *Asia-Pacific Cell and Gene Therapy Thawing Equipment Market*, By Modality (Benchtop and Portable), Sample (Cell Therapies and Gene Therapies), Type (Manual Thawing System and Automatic Thawing System), Application (Upstream Processing and Downstream Processing), End User (Blood Banks And Transfusion Centers, Hospitals and Diagnostic Laboratories, Research Laboratories And Academic Institutes, Biotechnology and Pharmaceutical Industry, Cord Blood and Stem Cell Banks, Gene Banks and Others), Distribution Channel (Direct Tender, Third Part Distributor and Others), Country (China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific) https://www.databridgemarketresearch.com/reports/asia-pacific-cell-and-gene-therapy-thawing-equipment-market
· *Middle East and Africa Cell and Gene Therapy Thawing Equipment Market*, By Modality (Benchtop and Portable), Sample (Cell Therapies and Gene Therapies), Type (Manual Thawing System and Automatic Thawing System), Application (Upstream Processing and Downstream Processing), End User (Blood Banks And Transfusion Centres, Hospitals and Diagnostic Laboratories, Research Laboratories And Academic Institutes, Biotechnology and Pharmaceutical Industry, Cord Blood and Stem Cell Banks, Gene Banks and Others), Distribution Channel (Direct Tender, Third Part Distributor and Others), Country (South Africa, Saudi Arabia, U.A.E., Egypt, Israel and Rest of Middle East And Africa) https://www.databridgemarketresearch.com/reports/middle-east-and-africa-cell-and-gene-therapy-thawing-equipment-market
· *North America Cell and Gene Therapy Thawing Equipment Market*, By Modality (Benchtop and Portable), Sample (Cell Therapies and Gene Therapies), Type (Manual Thawing System and Automatic Thawing System), Application (Upstream Processing and Downstream Processing), End User (Blood Banks And Transfusion Centers, Hospitals and Diagnostic Laboratories, Research Laboratories And Academic Institutes, Biotechnology and Pharmaceutical Industry, Cord Blood and Stem Cell Banks, Gene Banks and Others), Distribution Channel (Direct Tender, Third Part Distributor and Others), Country (U.S., Canada, Mexico) https://www.databridgemarketresearch.com/reports/north-america-cell-and-gene-therapy-thawing-equipment-market
· *Europe Cell and Gene Therapy Thawing Equipment Market*, By Modality (Benchtop and Portable), Sample (Cell Therapies and Gene Therapies), Type (Manual Thawing System and Automatic Thawing System), Application (Upstream Processing and Downstream Processing), End User (Blood Banks And Transfusion Centers, Hospitals and Diagnostic Laboratories, Research Laboratories And Academic Institutes, Biotechnology and Pharmaceutical Industry, Cord Blood and Stem Cell Banks, Gene Banks and Others), Distribution Channel (Direct Tender, Third Part Distributor and Others), Country (U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Ireland, Rest of Europe) https://www.databridgemarketresearch.com/reports/europe-cell-and-gene-therapy-thawing-equipment-market
*
*
· *Next Generation Sequencing (NGS) Market*, By Product (Instruments, Consumables and Services), Applications (Diagnostics, Biomarker Discovery, Precision Medicine, Drug Discovery, Agriculture and Animal Research and Others), End User (Pharmaceutical & Biotechnology Companies, Research Centers & Academic and Government Institutes and Hospital & Clinics), Country (U.S., Canada, Mexico, Germany, U.K., Italy, France, Spain, Switzerland, Russia, Turkey, Belgium, Netherlands and Rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific, Brazil and Rest of South America, South Africa and Rest of Middle East And Africa) https://www.databridgemarketresearch.com/reports/global-next-generation-sequencing-ngs-market
*About Data Bridge Market Research:*
*An absolute way to forecast what future holds is to comprehend the trend today!*
*Data Bridge Market Research* set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
*Contact Us:*
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
*Email:-* *corporatesales@databridgemarketresearch.com*